Jia Wei

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Particulate Matter

Cancer Stem Cells

Top Venues

EMBO molecular medicine

Cancer medicine

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Keying Che, Yuting Luo, Xueru Song, Zhe Yang, Hanbing Wang, Tao Shi, Yue Wang, Xuan Wang, Hongyan Wu, Lixia Yu, Baorui Liu, Jia Wei
Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO molecular medicine 16 (2) (2024)
Keying Che, Yuting Luo, Xueru Song, Zhe Yang, Hanbing Wang, Tao Shi, Yue Wang, Xuan Wang, Hongyan Wu, Lixia Yu, Baorui Liu, Jia Wei
Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO molecular medicine 16 (2) (2024)
Keying Che, Yuting Luo, Xueru Song, Zhe Yang, Hanbing Wang, Tao Shi, Yue Wang, Xuan Wang, Hongyan Wu, Lixia Yu, Baorui Liu, Jia Wei
Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO molecular medicine 16 (2) (2024)
Keying Che, Yuting Luo, Xueru Song, Zhe Yang, Hanbing Wang, Tao Shi, Yue Wang, Xuan Wang, Hongyan Wu, Lixia Yu, Baorui Liu, Jia Wei
Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO molecular medicine (2024)
Yue Wang, Hanbing Wang, Tao Shi, Xueru Song, Xin Zhang, Yue Zhang, Xuan Wang, Keying Che, Yuting Luo, Lixia Yu, Baorui Liu, Jia Wei
Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer. EMBO molecular medicine (2024)
Keying Che, Yuting Luo, Xueru Song, Zhe Yang, Hanbing Wang, Tao Shi, Yue Wang, Xuan Wang, Hongyan Wu, Lixia Yu, Baorui Liu, Jia Wei
Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer. EMBO molecular medicine 16 (2) (2024)
Yuncheng Bei, Jian He, Xuhui Dong, Yuxin Wang, Sijie Wang, Wan Guo, Chengjie Cai, Zhiye Xu, Jia Wei, Baorui Liu, Nan Zhang, Ping-Ping Shen
Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma. Cancer research (2023)
Jia Wei, Xiaofeng Lu, Qin Liu, Yao Fu, Song Liu, Yang Zhao, Jiawei Zhou, Hui Chen, Meng Wang, Lin Li, Ju Yang, Fangcen Liu, Liming Zheng, Haitao Yin, Yang Yang, Chong Zhou, Ping Zeng, Xiaoyu Zhou, Naiqing Ding, Shiqing Chen, Xiaochen Zhao, Jing Yan, Xiangshan Fan, Wenxian Guan, Baorui Liu
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial. Nature communications 14 (1) (2023)
Yipeng Zhang, Kaijie Liang, Xiaoyu Zhou, Xin Zhang, Hui Xu, Hongjiu Dai, Xueru Song, Xueyi Yang, Baorui Liu, Tao Shi, Jia Wei
Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer. Cancer science (2023)
Fanyan Meng, Jun Liu, Jia Wei, Baorui Liu, Chong Zhou, Jing Yan, Baorui Liu
Tumor-penetrating peptide internalizing RGD enhances radiotherapy efficacy through reducing tumor hypoxia. Cancer science 113 (4) (2022)
Yuting Luo, Hanbing Wang, Baorui Liu, Jia Wei
Fatty Acid Metabolism and Cancer Immunotherapy. Current oncology reports 24 (5) (2022)
Bo Xu, Fangjun Chen, Xin Zhang, Zhongda Wang, Keying Che, Nandie Wu, Lixia Yu, Xiangshan Fan, Baorui Liu, Jia Wei
Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer. Cancers 14 (11) (2022)
Tao Shi, Yipeng Zhang, Yue Wang, Xueru Song, Hanbing Wang, Xiaoyu Zhou, Kaijie Liang, Yuting Luo, Keying Che, Xuan Wang, Yunfeng Pan, Fangcen Liu, Ju Yang, Qin Liu, Lixia Yu, Baorui Liu, Jia Wei
DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer. Cancer immunology research 10 (12) (2022)
Xuan Wang, Keying Che, Tao Shi, Qin Liu, Xinyun Xu, Hongyan Wu, Lixia Yu, Baorui Liu, Jia Wei
Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer. Journal of cancer research and clinical oncology 148 (7) (2022)
Qin Wang, Ying-Tzu Yen, Chen Xie, Fangcen Liu, Qin Liu, Jia Wei, Lixia Yu, Lifeng Wang, Fanyan Meng, Ru-Tian Li, Baorui Liu
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells. Drug delivery 28 (1) (2021)
Yue Wang, Tao Shi, Xuan Wang, Jinwei Hu, Lixia Yu, Qin Liu, Nandie Wu, Baorui Liu, Jia Wei
FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma. Journal of translational medicine 19 (1) (2021)
Xiaoxiao Yu, Jiayao Yan, Xiaotong Chen, Jia Wei, Lixia Yu, Fangcen Liu, Lin Li, Baorui Liu
Identification of a peptide binding to cancer antigen Kita-kyushu lung cancer antigen 1 from a phage-display library. Cancer science 112 (10) (2021)
Yunfeng Pan, Xueru Song, Yue Wang, Jia Wei
Firing up the Tumor Microenvironment with Nanoparticle-Based Therapies. Pharmaceutics 13 (9) (2021)
Keying Che, Fangcen Liu, Nandie Wu, Qin Liu, Ling Yuan, Jia Wei
Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer. Cancer medicine 9 (19) (2020)
Tao Shi, Xueru Song, Qin Liu, Yang Yang, Lixia Yu, Baorui Liu, Jia Wei
Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study. Cancer medicine 8 (13) (2019)